Gemfibrozil improves insulin sensitivity and flow‐mediated vasodilatation in type 2 diabetic patients

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Background

Endothelial dysfunction is an early feature of atherosclerosis. The relationship between insulin action and hypertriglyceridaemia on endothelial function is still debated. Materials and Methods

This study was designed to determine the effect of a 3 month treatment with Gemfibrozil (GF) on flow-mediated vasodilatation and insulin sensitivity. Ten type 2 diabetic patients were randomised in crossover, double blind fashion, either to GF, 600 mg b.i.d. or placebo, for 12 weeks. Lipid profile, low-density lipoprotein (LDL) distribution and flotation properties, insulin action and flow-mediated vasodilatation (FMD) by brachial artery ultrasound, were assessed. Results

GF decreased serum triglyceride (TG) concentration with an absolute difference of 1·79 ± 1·28 mmol L−1 (P < 0·0016) between active treatment and placebo, and significantly increased serum high-density lipoprotein (HDL) cholesterol (P = 0·0233). No differences were observed in total, intermediate‐density lipoproteins (IDL) , LDL cholesterol concentration and LDL peak buoyancy between treatments. GF also improved SI, an index of insulin action (P = 0·005). The FMD was 7 ± 3% in the baseline condition, 7 ± 2% during placebo and 14 ± 3% after GF (P < 0·006). Conclusions

GF treatment improves both insulin action and flow-mediated vasodilatation in type 2 diabetic patients. The reduction of TG concentration allows the simultaneous correction of two important components of the metabolic syndrome.

Keywords: Diabetes mellitus; endothelium; insulin action; lipoproteins; triglycerides

Document Type: Research Article

DOI: http://dx.doi.org/10.1046/j.1365-2362.2001.00856.x

Affiliations: 1: University of Padova, Padova, Italy, 2: LADSEB CNR, Padova, Italy, 3: Parke-Davis Italia, Lainate, Milan, Italy

Publication date: July 1, 2001

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more